Bioventix PLC (BVXP) Announces GBX 30 Dividend

Bioventix PLC (LON:BVXP) declared a dividend on Friday, March 29th, Upcoming.Co.Uk reports. Shareholders of record on Thursday, April 11th will be paid a dividend of GBX 30 ($0.39) per share by the biotechnology company on Friday, April 26th. This represents a yield of 0.79%. The ex-dividend date of this dividend is Thursday, April 11th. The official announcement can be seen at this link.

BVXP remained flat at $GBX 3,965 ($51.81) during midday trading on Friday. The company’s stock had a trading volume of 9,611 shares, compared to its average volume of 5,505. Bioventix has a 52-week low of GBX 2,530 ($33.06) and a 52-week high of GBX 4,060 ($53.05). The firm has a market cap of $203.91 million and a P/E ratio of 37.13.

Separately, FinnCap boosted their target price on Bioventix from GBX 3,400 ($44.43) to GBX 3,700 ($48.35) and gave the company a “corporate” rating in a research report on Friday, March 29th.

COPYRIGHT VIOLATION WARNING: This article was originally reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this article on another site, it was illegally stolen and reposted in violation of US and international copyright law. The original version of this article can be read at

About Bioventix

Bioventix PLC manufactures and supplies sheep monoclonal antibodies (SMAs) for use in blood-testing machines in hospitals and other labs worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications.

Further Reading: The Role of a Fiduciary and Individual Investors

Dividend History for Bioventix (LON:BVXP)

Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with's FREE daily email newsletter.